Tusk Pharmaceuticals Llp - Company Profile

It is a pharma limited liability partnership based in Mumbai, Maharashtra, India, established in 2017.
2017 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Tusk Pharmaceuticals Llp

Tusk Pharmaceuticals Llp, a active limited liability partnership, was established on 14 February 2017 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAI-5535. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹10.00 K .

Its leadership includes Anshuman Goyal (Designated Partner), Girish Ramesh Rathod (Designated Partner), Tushar Bharatkumar Lodaya (Designated Partner). It is based at 1105, B-Wing, Naman Midtown, Next To Indiabulls Finance Centre, Tulsi Pipe Road, Elphist, One West, Mumbai, Maharashtra, 400013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAI-5535

  • Incorporation Date

    14 February 2017

  • Total Obligation of Contribution

    ₹10.00 K

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 10.00 K
  • Company Age 9 Year, 4 Months
Company report

Tusk Pharmaceuticals Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Tusk Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Tusk Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Anshuman Goyal Designated Partner 14 Feb 2017 Current
Girish Ramesh Rathod Designated Partner 14 Feb 2017 Current
Tushar Bharatkumar Lodaya Designated Partner 14 Feb 2017 Current
Ravindra Popat Bhalerao Designated Partner 14 Feb 2017 Current
Mangesh Madanlal Dhalawat Designated Partner 14 Feb 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tusk Pharmaceuticals Llp.

Enhance accessibility to Tusk Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Tusk Pharmaceuticals Llp revenue growth over time
Tusk Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tusk Pharmaceuticals Llp?

Unlock access to Tusk Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Tusk Pharmaceuticals Llp?

Unlock and access historical data on people associated with Tusk Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tusk Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tusk Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tusk Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Tusk Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2018 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Anshuman Goyal was appointed as a Designated Partner was appointed as a Designated Partner on 14 Feb 2017 & has been associated with this company since 9 years 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Girish Ramesh Rathod was appointed as a Designated Partner was appointed as a Designated Partner on 14 Feb 2017 & has been associated with this company since 9 years 4 months . was completed.

  • Director Appointment

    Tushar Bharatkumar Lodaya was appointed as a Designated Partner was appointed as a Designated Partner on 14 Feb 2017 & has been associated with this company since 9 years 4 months . was recorded as a recent event.

  • Director Appointment

    Progress on Ravindra Popat Bhalerao was appointed as a Designated Partner was appointed as a Designated Partner on 14 Feb 2017 & has been associated with this company since 9 years 4 months . was documented.

  • Director Appointment

    Progress on Mangesh Madanlal Dhalawat was appointed as a Designated Partner was appointed as a Designated Partner on 14 Feb 2017 & has been associated with this company since 9 years 4 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Tusk Pharmaceuticals Llp?

The LLPIN of Tusk Pharmaceuticals Llp is AAI-5535.

Where is Tusk Pharmaceuticals Llp headquartered?

Tusk Pharmaceuticals Llp is headquartered at 1105, B-Wing, Naman Midtown, Next To Indiabulls Finance Centre, Tulsi Pipe Road, Elphist, One West, Mumbai, Maharashtra, 400013.

When was Tusk Pharmaceuticals Llp incorporated?

Tusk Pharmaceuticals Llp was incorporated on 14 February 2017.

Who are the current directors of Tusk Pharmaceuticals Llp?

The current directors of Tusk Pharmaceuticals Llp are

What is the primary industry of Tusk Pharmaceuticals Llp?

The primary industry of Tusk Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available